Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

markets.businessinsider.com
markets.businessinsider.com > news > stocks > rema-hort-mann-fund-celebrates-30-years-of-art-and-care-with-milestone-gala-and-launch-of-new-chapter-of-expanded-grantmaking-with-artists-living-with-cancer-grant-1036536984

Rema Hort Mann Fund Celebrates 30 Years of Art and Care with Milestone Gala and Launch of New Chapter of Expanded Grantmaking with Artists Living with Cancer Grant

2+ day, 23+ hour ago   (296+ words) New York City, Sept. 10, 2026 (GLOBE NEWSWIRE) -- ABOUT RHMF’s 30th ANNIVERSARY GALA HONOREES Susan Hort, a passionate advocate for early-career artists, is also a revered philanthropist and seasoned collector of contemporary art. Listed numerous times on the ARTnews Top 200 Collector List, alongside…...

markets.businessinsider.com
markets.businessinsider.com > news > stocks > oncolytics-biotech-announces-positive-preclinical-results-combining-pelareorep-with-a-pan-ras-inhibitor-in-colorectal-cancer-1036535740

Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer

3+ day, 4+ hour ago   (398+ words) Preclinical results demonstrate pelareorep activity is maintained in the presence of RAS inhibitionFindings support further evaluation of pelareor... Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer Preclinical results demonstrate pelareorep activity is maintained…...

ynetglobal
ynetnews.com > tech-and-digital > article > bjiqzvzymx

'Israeli talent is amazing, but we're facing a serious problem': Google Israel CEO opens up

19+ hour, 6+ min ago   (1771+ words) Google Israel CEO Barak Regev reflects on his rise from teenage orange seller to tech executive, a confrontation with a pro-Palestinian engineer, anti-Israel backlash, Wiz's success and the AI revolution It happened two years ago, on March 4, at a Calcalist…...

The Fox Says
manifund.substack.com > p > caroline-ellison-has-joined-manifund

Caroline Ellison has joined Manifund

1+ day, 7+ hour ago   (734+ words) Austin: I’m happy to announce that Caroline Ellison has accepted a role at Manifund, to develop our funding platform and research how to effectively direct philanthropic dollars. In fact, she started a work trial on July 13, which converted to a…...

Yahoo Finance
finance.yahoo.com > healthcare > articles > alloy-therapeutics-named-winner-fast-120000666.html

Alloy Therapeutics Named a Winner on Fast Company’s 2026 Best Workplaces for Innovators List

3+ day, 26+ min ago   (403+ words) BOSTON, September 10, 2026--Fast Company has named Alloy Therapeutics a winner on its 2026 Biotech, Healthcare, and Life Sciences list as part of the publication’s eighth annual Best Workplaces for Innovators program. The recognition celebrates organizations that create cultures where innovation can…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:4151825:0-nbp-advancing-innovative-cancer-and-ophthalmology-therapies-with-global-expansion-and-new-partnerships

NBP: Advancing innovative cancer and ophthalmology therapies with global expansion and new partnerships

2+ day, 11+ hour ago   (77+ words) TradingView The conference highlighted progress on a bispecific therapy for gastric cancer, with phase III trials and potential expansion into pancreatic and biliary cancers. The company is also advancing an ophthalmology asset aiming for less frequent dosing, while exploring new…...

BioSpace
biospace.com > press-releases > immuno-oncology-pioneer-dr-michael-kalos-joins-kos-biotechnology-partners-as-venture-partner

Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner

1+ day, 22+ hour ago   (313+ words) NEW YORK and ATHENS, Greece, Sept. 10, 2026 /PRNewswire/ -- Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael Kalos, PhD, as Venture Partner. Dr. Kalos brings decades of biopharmaceutical executive leadership, drug discovery,…...

tricitiesbusinessnews.com
tricitiesbusinessnews.com > articles > 8363-bankruptcies-september-2026

Bankruptcies – September 2026

2+ day, 14+ hour ago   (259+ words) Bankruptcies are filed under the following chapter headings: Chapter 7 — Straight Bankruptcy: debtor gives up non-exempt property and debt is discharged. Chapter 11 — Allows companies and individuals to restructure debts to repay them. Chapter 12 — Allows family farmers or fishermen to restructure finances…...

AllSci
allsci.com > news > funding > neonc-funding-cns-cancer-raises-usd-15m-to

NeOnc raises USD 15m to advance Phase II CNS cancer programs after NEO100 efficacy readout

2+ day, 11+ hour ago   (319+ words) AllSci California-based NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) announced a USD 15 million registered direct offering on September 9, 2026, with proceeds directed toward advancing its two central nervous system (CNS) cancer therapeutics through ongoing Phase II trials. The timing follows positive topline…...

@LBBOnline
lbbonline.com > news > phd-aotearoa-sarah-wilson-alice-franklin-georgia-gardien

PHD Aotearoa Hires Head of Digital Engagement, Two Senior Client Roles | LBBOnline

2+ day, 4+ hour ago   (391+ words) PHD Aotearoa continues to strengthen its senior and specialist offering with the appointment of Sarah Wilson as head of digital enablement -- a newly created role -- Alice Franklin as client service director, and Georgia Gardien as senior account director, PHD Content....